PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy
AID  - 10.1136/jitc-2021-003960corr1
DP  - 2022 Sep 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e003960corr1
VI  - 10
IP  - 9
4099  - http://jitc.bmj.com/content/10/9/e003960corr1.short
4100  - http://jitc.bmj.com/content/10/9/e003960corr1.full
SO  - J Immunother Cancer2022 Sep 01; 10